French squeeze on generics adds to industry's woes
This article was originally published in Scrip
Executive Summary
The French health ministry has announced that the pharmaceutical industry will be called on to make a further contribution of €290 million in 2012 as a result of the cut in the annual target rate for growth in healthcare expenditure over the next few years.